JP2017519802A5 - - Google Patents

Download PDF

Info

Publication number
JP2017519802A5
JP2017519802A5 JP2017500886A JP2017500886A JP2017519802A5 JP 2017519802 A5 JP2017519802 A5 JP 2017519802A5 JP 2017500886 A JP2017500886 A JP 2017500886A JP 2017500886 A JP2017500886 A JP 2017500886A JP 2017519802 A5 JP2017519802 A5 JP 2017519802A5
Authority
JP
Japan
Prior art keywords
group
alkyl
substituted
alkoxy
halogen
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
JP2017500886A
Other languages
English (en)
Japanese (ja)
Other versions
JP2017519802A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/EP2015/065868 external-priority patent/WO2016005576A1/en
Publication of JP2017519802A publication Critical patent/JP2017519802A/ja
Publication of JP2017519802A5 publication Critical patent/JP2017519802A5/ja
Withdrawn legal-status Critical Current

Links

JP2017500886A 2014-07-11 2015-07-10 犬糸状虫に対する駆虫薬の使用 Withdrawn JP2017519802A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP14176733.5 2014-07-11
EP14176733 2014-07-11
PCT/EP2015/065868 WO2016005576A1 (en) 2014-07-11 2015-07-10 Use of anthelmintic agents against dirofilaria immitis

Publications (2)

Publication Number Publication Date
JP2017519802A JP2017519802A (ja) 2017-07-20
JP2017519802A5 true JP2017519802A5 (OSRAM) 2018-08-16

Family

ID=51167758

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2017500886A Withdrawn JP2017519802A (ja) 2014-07-11 2015-07-10 犬糸状虫に対する駆虫薬の使用

Country Status (7)

Country Link
US (2) US10010538B2 (OSRAM)
EP (1) EP3177291A1 (OSRAM)
JP (1) JP2017519802A (OSRAM)
CN (1) CN106659720A (OSRAM)
AU (1) AU2015286634A1 (OSRAM)
BR (1) BR112017000398A2 (OSRAM)
WO (1) WO2016005576A1 (OSRAM)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK3448859T3 (da) 2017-03-20 2019-09-23 Forma Therapeutics Inc Pyrrolopyrrolsammensætninger som pyruvatkinase- (pkr) aktivatorer
IL283725B2 (en) 2017-06-20 2024-04-01 Imbria Pharmaceuticals Inc Compositions and methods for increasing efficiency of cardiac metabolism
WO2020061378A1 (en) 2018-09-19 2020-03-26 Forma Therapeutics, Inc. Treating sickle cell disease with a pyruvate kinase r activating compound
JP7450610B2 (ja) 2018-09-19 2024-03-15 ノヴォ・ノルディスク・ヘルス・ケア・アーゲー ピルビン酸キナーゼrの活性化
WO2020081361A1 (en) 2018-10-17 2020-04-23 Imbria Pharmaceuticals, Inc. Methods of treating rheumatic diseases using trimetazidine-based compounds
MX2022003254A (es) 2019-09-19 2022-04-18 Forma Therapeutics Inc Composiciones activadoras de piruvato cinasa r (pkr).
US11780811B2 (en) 2020-06-30 2023-10-10 Imbria Pharmaceuticals, Inc. Methods of synthesizing 2-[4-[(2,3,4-trimethoxyphenyl)methyl]piperazin-1-yl]ethyl pyridine-3-carboxylate
US11530184B2 (en) 2020-06-30 2022-12-20 Imbria Pharmaceuticals, Inc. Crystal forms of 2-[4-[(2,3,4-trimethoxyphenyl)methyl]piperazin-1-yl]ethyl pyridine-3-carboxylate
US12128035B2 (en) 2021-03-19 2024-10-29 Novo Nordisk Health Care Ag Activating pyruvate kinase R
US11883396B2 (en) 2021-05-03 2024-01-30 Imbria Pharmaceuticals, Inc. Methods of treating kidney conditions using modified forms of trimetazidine

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK0810823T3 (da) 1995-02-24 2001-07-23 Novartis Ag Sammensætning til bekæmpelse af parasitter
TW200938203A (en) * 2007-12-17 2009-09-16 Intervet Int Bv Anthelmintic agents and their use
TW201041868A (en) 2009-03-20 2010-12-01 Intervet Int Bv Anthelmintic agents and their use
TW201111358A (en) 2009-06-18 2011-04-01 Intervet Int Bv Anthelmintic agents and their use
EP2468096A1 (en) 2010-12-21 2012-06-27 Intervet International BV Anthelmintic combinations
NZ723198A (en) 2012-11-20 2018-11-30 Boehringer Ingelheim Animal Health Usa Inc Anthelmintic compounds and compositions and methods of using thereof

Similar Documents

Publication Publication Date Title
JP2017519802A5 (OSRAM)
RU2487124C2 (ru) Новое амидное производное и его использование в качестве лекарственного средства
MX2021005087A (es) Compuestos de formula i para usarse en el tratamiento de infecciones por virus arenaviridae y coronaviridae.
JP2014101347A5 (OSRAM)
RU2014129742A (ru) Производные бензолсульфонамида в качестве модуляторов rorc
MA37712B1 (fr) Inhibiteurs macrocycliques de virus flaviviridae
CY1118721T1 (el) Παραγωγα 2,3 διϋδρο-1η-ινδεν-1-υλ-2,7-διαζασπειρο[3.6]εννεανιου και η χρηση αυτων ως ανταγωνιστες ή αντιστροφοι αγωνιστες του υποδοχεα γκρελινης
EA201201162A1 (ru) Фунгицидные смеси, содержащие замещенные 1-метилпиразол-4-илкарбоксанилиды
JP2018501226A5 (OSRAM)
EA201001126A1 (ru) Пирролопиримидины и пирролопиридины
BR112015021027A8 (pt) compostos terapêuticos, seus usos, e composições farmacêuticas
EA201001455A1 (ru) Пиридины и пиразины в качестве ингибиторов pi3k (фосфатидилинозиткиназы-3)
JP2015522650A5 (OSRAM)
EA201391486A1 (ru) Способы и композиции для лечения болезни паркинсона
JP2013530176A5 (OSRAM)
AR077143A1 (es) Compuestos insecticidas
EA200801996A1 (ru) 2-замещенные производные 4-бензилфталазинонов в качестве гистаминовых h1- и h3-антагонистов
EA201100750A1 (ru) Замещенные диоксопиперидинилфталимидные производные
RU2014112048A (ru) Пиразольное соединение и его применение в фармацевтике
EA201590023A1 (ru) Новые 4-замещенные производные 1,3-дигидро-2h-бензимидазол-2-она, замещенные бензимидазолами, в качестве противовирусных средств против респираторного синцитиального вируса
MA32727B1 (fr) Pyrazolylaminopyridines au titre d'inhibiteurs de fak
AR072459A1 (es) DERIVADOS DE DIONAS CICLICAS ACTIVAS COMO HERBICIDAS, PROCESO DE PREPARACIoN Y COMPOSICIONES QUE COMPRENDEN DICHOS COMPUESTOS
PE20090984A1 (es) Inhibidores de peptido desformilasa
JP2016513696A5 (OSRAM)
ATE540037T1 (de) Triazolopyridine als phosphodiesterasehemmer zur behandlung von hautkrankheiten